Matinas BioPharma Holdings, Inc.
MTNB
$0.59
-$0.05-7.84%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.91M | -1.53M | -5.25M | -1.66M | -8.43M |
| Total Depreciation and Amortization | 95.00K | 111.00K | 122.00K | 128.00K | 247.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 531.00K | 253.00K | 3.58M | 21.00K | 4.59M |
| Change in Net Operating Assets | -223.00K | -306.00K | -481.00K | -500.00K | 86.00K |
| Cash from Operations | -1.51M | -1.47M | -2.02M | -2.01M | -3.51M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 15.00K | 320.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 500.00K |
| Cash from Investing | 15.00K | 320.00K | -- | -- | 500.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -7.00K | 0.00 | -1.00K | -1.00K | -1.00K |
| Issuance of Common Stock | 65.00K | 64.00K | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 0.00 | 3.30M | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -1.68M | 1.65M | -- |
| Cash from Financing | 58.00K | 64.00K | 1.62M | 1.65M | -1.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.44M | -1.09M | -399.00K | -360.00K | -3.01M |